Cetirizine Hydrochloride 10 mg Tablets Labeling Error Recall
A-S Medication Solutions LLC is recalling Cetirizine hydrochloride 10 mg tablets due to a labeling error: bottles were labeled as 90-count when they actually contain 30 tablets.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is a labeling discrepancy involving tablet count without any reported safety hazard, injury, or illness. The source text classifies this as "Not Elsewhere classified" and the FDA classification is Class III, making this a packaging/labeling documentation issue that constitutes a Low severity recall.
Plain-English summary
A-S Medication Solutions LLC is recalling Cetirizine hydrochloride 10 mg tablets due to incorrect labeling. The product was relabeled as a 90-count bottle despite containing only 30 tablets from the manufacturer.
The affected product is Cetirizine hydrochloride 10 mg tablets in 90-count bottles, manufactured by Major Pharmaceuticals (Livonia, MI) and distributed by A-S Medication Solutions (Libertyville, IL). The recalled lot number is 1256330, with 72 bottles distributed across Florida, Indiana, Minnesota, and Wisconsin. The product NDC is 50090-5510-3.
Consumers who have purchased this product should verify the actual tablet count in their bottle matches the label. If the bottle is labeled as 90 tablets but contains fewer tablets, it should not be used. Consumers with questions should contact A-S Medication Solutions.
The recalled product
- Product
- CETIRIZINE (CETIRIZINE HYDROCHLORIDE)
- Brand
- CETIRIZINE
- Manufacturer
- A-S Medication Solutions LLC.
- Hazard
- mis-labeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 1256330
Distribution
Distributed in 4 states:
- FL
- IN
- MN
- WI
Related recalls
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22